W
WSI Co Ltd
KOSDAQ:299170
WSI Co Ltd
KOSDAQ:299170
Price:
3 210
KRW
Market Closed
Market Cap:
₩133.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
WSI Co Ltd
Net Change in Cash
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
WSI Co Ltd
Net Change in Cash Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
W
|
WSI Co Ltd
KOSDAQ:299170
|
Net Change in Cash
-₩1.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-118%
|
CAGR 10-Years
N/A
|
|
|
C
|
Chorokbaem Healthcare Co Ltd
KRX:118000
|
Net Change in Cash
-₩28.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-52%
|
CAGR 10-Years
-48%
|
|
|
W
|
Wonik Co Ltd
KOSDAQ:032940
|
Net Change in Cash
-₩6.4B
|
CAGR 3-Years
-48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Life Science Co Ltd
KOSDAQ:067630
|
Net Change in Cash
-₩39.4B
|
CAGR 3-Years
-423%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
BlueMTec Co Ltd
KOSDAQ:439580
|
Net Change in Cash
-₩12.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
WSI Co Ltd
Glance View
WSI Co., Ltd. manufactures medical devices and pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-09-21. The firm mainly distributes the topical hemostatic agent Flosils. In addition, the Company supplies endoscopes related to spinal surgery, anti-adhesion agents, and bone hemostatic agents.
Intrinsic Value
1 696.71
KRW
Overvaluation 47%
W
See Also
What is WSI Co Ltd's Net Change in Cash?
Net Change in Cash
-1.9B
KRW
-1.9B
KRW
Based on the financial report for Dec 31, 2024, WSI Co Ltd's Net Change in Cash amounts to -1.9B KRW.
What is WSI Co Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
-118%
-118%
Over the last year, the Net Change in Cash growth was 73%.
